内科学
伊诺斯
蛋白激酶B
内分泌学
胰岛素受体
信号转导
磷酸化
一氧化氮合酶Ⅲ型
医学
一氧化氮合酶
IRS1
一氧化氮
胰岛素
内皮功能障碍
细胞生物学
生物
胰岛素抵抗
作者
Massimo Federici,Rossella Menghini,Alessandro Mauriello,Marta Letizia Hribal,Francesca Ferrelli,Davide Lauro,Paolo Sbraccia,Luigi Giusto Spagnoli,Giorgio Sesti,Renato Lauro
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2002-07-23
卷期号:106 (4): 466-472
被引量:409
标识
DOI:10.1161/01.cir.0000023043.02648.51
摘要
BACKGROUND: Hyperglycemia impairs functional properties of cytosolic and nuclear proteins via O-linked glycosylation modification (O-GlcNAcylation). We studied the effects of O-GlcNAcylation on insulin signaling in human coronary artery endothelial cells. METHODS AND RESULTS: O-GlcNAcylation impaired the metabolic branch of insulin signaling, ie, insulin receptor (IR) activation of the IR substrate (IRS)/phosphatidylinositol 3-kinase (PI3-K)/Akt, whereas it enhanced the mitogenic branch, ie, ERK-1/2 and p38 (mitogen-activated protein kinase). Both in vivo and in vitro phosphorylation of endothelial nitric oxide synthase (eNOS) by Akt were reduced by hyperglycemia and hexosamine activation. Insulin-induced eNOS activity in vivo was reduced by hyperglycemia and hexosamine activation, which was coupled to increased activation and expression of matrix metalloproteinase-2 and -9; these phenomena were reversed by inhibition of the hexosamine pathway. Finally, carotid plaques from type 2 diabetic patients showed increased endothelial O-GlcNAcylation with respect to nondiabetics. CONCLUSIONS: Our data show that hyperglycemia, through the hexosamine pathway, impairs activation of the IR/IRS/PI3-K/Akt pathway, resulting in deregulation of eNOS activity.
科研通智能强力驱动
Strongly Powered by AbleSci AI